Login
CHAMPIONS ONCOLOGY, INC. logo

CHAMPIONS ONCOLOGY, INC.

championsoncology.com

What Do They Do?

Provides preclinical cancer-drug studies and PDX data to pharmaceutical and biotechnology companies, offers cancer-research software to scientists, and develops oncology drugs.

How Do They Make Money?

Pharmaceutical and biotechnology companies pay fixed fees for research studies, generally invoiced on milestones as the work progresses. PDX data access is sold for a fixed fee upfront, while Lumin is sold by annual subscription.

revenue
SegmentShareRevenue
Pharmacology services
Recurring

96%
FY2023: 94%
TOS data license revenue
Licensed
1.3%
Other TOS revenue
2.6%
FY2023: 5.7%

Who Are Their Customers?

Pharmaceutical and biotechnology companies buy research services directly through the company’s sales force and also license PDX data. Cancer research scientists are customers for Lumin software, which is sold by annual subscription.

Customers above 10% of revenue, FY2026
of revenue from one customer
FY2025: 23% from two customers

Do Revenues Turn Into Profits?

No. It lost $1.2M in FY2026.

Operating income, FY2026
−2% of revenue
▼ Turned to a loss vs FY2025 ($4.6M, 8%)
Net income, FY2026
−2% of revenue
▼ Turned to a loss vs FY2025 ($4.7M, 8%)
Free cash flow, FY2026
−8% of revenue
▼ Turned to a loss vs FY2025 ($7M, 12%)

How Are They Changing?

Since the FY2026 annual report
Latest quarter: Q1 FY2027, the three months to Jul 31, 2026
Revenue
▲ +9%
vs $14M in Q1 FY2026
Net income
▲ +9% (Loss)
vs −$466K in Q1 FY2026
Pharmacology services share of revenue vs 94.5% in Q1 FY2026

Growing. Revenue grew 21% in 4 years, from $49.1M in FY2022 to $59.4M in FY2026, about 5% a year.

Revenue over time
Pharmacology services TOS data license revenue Other TOS revenue Personalized oncology services
$100M$50M$0

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support